|
1
|
Zhou L, Chong MM and Littman DR:
Plasticity of CD4(+) T cell lineage differentiation. Immunity.
30:646–655. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tan C, Aziz MK, Lovaas JD, Vistica BP, Shi
G, Wawrousek EF and Gery I: Antigen-specific Th9 cells exhibit
uniqueness in their kinetics of cytokine production and short
retention at the inflammatory site. J Immunol. 185:6795–6801. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shi G, Cox CA, Vistica BP, Tan C,
Wawrousek EF and Gery I: Phenotype switching by
inflammation-inducing polarized Th17 cells, but Not by Th1 cells. J
Immunol. 181:7205–7213. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kabata H, Moro K and Koyasu S: The group 2
innate lymphoid cell (ILC2) regulatory network and its underlying
mechanisms. Immunol Rev. 286:37–52. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Noelle RJ and Nowak EC: Cellular sources
and immune functions of interleukin-9. Nat Rev Immunol. 10:683–687.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Purwar R, Schlapbach C, Xiao S, Kang HS,
Elyaman W, Jiang X, Jetten AM, Khoury SJ, Fuhlbrigge RC, Kuchroo
VK, et al: Robust tumor immunity to melanoma mediated by
interleukin-9-producing T cells. Nat Med. 18:1248–1253. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Veldhoen M, Uyttenhove C, van Snick J,
Helmby H, Westendorf A, Buer J, Martin B, Wilhelm C and Stockinger
B: Transforming growth factor-beta ‘reprograms’ the differentiation
of T helper 2 cells and promotes an interleukin 9-producing subset.
Nat Immunol. 9:1341–1346. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schmitt E, Germann T, Goedert S, Hoehn P,
Huels C, Koelsch S, Kühn R, Müller W, Palm N and Rüde E: IL-9
production of naive CD4+ T cells depends on IL-2, is
synergistically enhanced by a combination of TGF-beta and IL-4, and
is inhibited by IFN-gamma. J Immunol. 153:39891994.PubMed/NCBI
|
|
9
|
Schmitt E, Beuscher HU, Huels C, Monteyne
P, van Brandwijk R, van Snick J and Ruede E: IL-1 serves as a
secondary signal for IL-9 expression. J Immunol. 147:3848–3854.
1991.PubMed/NCBI
|
|
10
|
Angkasekwinai P, Chang SH, Thapa M,
Watarai H and Dong C: Regulation of IL-9 expression by IL-25
signaling. Nat Immunol. 11:250–256. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tamiya T, Ichiyama K, Kotani H, Fukaya T,
Sekiya T, Shichita T, Honma K, Yui K, Matsuyama T, Nakao T, et al:
Smad2/3 and IRF4 play a cooperative role in IL-9-producing t cell
induction. J Immunol. 191:2360–2371. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ji L, Xu J, Liu J, Amjad A, Zhang K, Liu
Q, Zhou L, Xiao J and Li X: Mutant p53 promotes tumor cell
malignancy by both positive and negative regulation of the
transforming growth factor β (TGF-β) pathway. J Biol Chem.
290:11729–11740. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu P, Ji X, Wan J and Xu H: Activity of
group 2 innate lymphoid cells is associated with chronic
inflammation and dysregulated metabolic homoeostasis in type 2
diabetic nephropathy. Scand J Immunol. 87:99–107. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dardalhon V, Awasthi A, Kwon H, Galileos
G, Gao W, Sobel RA, Mitsdoerffer M, Strom TB, Elyaman W, Ho IC, et
al: IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together
with TGF-beta, generates IL-9+ IL-10+ Foxp3(−) effector T cells.
Nat Immunol. 9:1347–1355. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stassen M, Schmitt E and Bopp T: From
interleukin-9 to T helper 9 cells. Ann N Y Acad Sci. 1247:56–68.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chang HC, Sehra S, Goswami R, Yao W, Yu Q,
Stritesky GL, Jabeen R, McKinley C, Ahyi AN, Han L, et al: The
transcription factor PU.1 is required for the development of
IL-9-producing T cells and allergic inflammation. Nat Immunol.
11:527–534. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Goswami R and Kaplan MH: Gcn5 Is required
for PU.1-dependent IL-9 induction in th9 cells. J Immunol.
189:3026–3033. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Staudt V, Bothur E, Klein M, Lingnau K,
Reuter S, Grebe N, Gerlitzki B, Hoffmann M, Ulges A, Taube C, et
al: Interferon-regulatory factor 4 is essential for the
developmental program of T helper 9 cells. Immunity. 33:192–202.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Goswami R, Jabeen R, Yagi R, Pham D, Zhu
J, Goenka S and Kaplan MH: STAT6-Dependent Regulation of Th9
Development. J Immunol. 188:968–975. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liao W, Lin JX and Leonard WJ: IL-2 family
cytokines: New insights into the complex roles of IL-2 as a broad
regulator of T helper cell differentiation. Curr Opin Immunol.
23:598–604. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin PY, Jen HY, Chiang BL, Sheu F and
Chuang YH: Interleukin-21 suppresses the differentiation and
functions of T helper 2 cells. Immunology. 144:668–676. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wong MT, Ye JJ, Alonso MN, Landrigan A,
Cheung RK, Engleman E and Utz PJ: Regulation of human Th9
differentiation by type I interferons and IL-21. Immunol Cell Biol.
88:624–631. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Murugaiyan G, Beynon V, Pires Da Cunha A,
Joller N and Weiner HL: IFN-gamma limits Th9 mediated autoimmune
inflammation through dendritic cell modulation of IL-27. J Immunol.
253:69. 2012.
|
|
24
|
Ye J, Wang Y, Wang Z, Ji Q, Huang Y, Zeng
T, Hu H, Ye D, Wan J and Lin Y: Circulating Th1, Th2, Th9, Th17,
Th22, and treg levels in aortic dissection patients. Mediators
Inflamm. 2018:56971492018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tan C, Wei L, Vistica BP, Shi G, Wawrousek
EF and Gery I: Phenotypes of Th lineages generated by the commonly
used activation with anti-CD3/CD28 antibodies differ from those
generated by the physiological activation with the specific
antigen. Cell Mol Immunol. 11:305–313. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jabeen R and Kaplan MH: The symphony of
the ninth: the development and function of Th9 cells. Curr Opin
Immunol. 24:303–307. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Heldin CH, Landström M and Moustakas A:
Mechanism of TGF-beta signaling to growth arrest, apoptosis, and
epithelial-mesenchymal transition. Curr Opin Cell Biol. 21:166–176.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Murillo MM, del Castillo G, Sánchez A,
Fernández M and Fabregat I: Involvement of EGF receptor and c-Src
in the survival signals induced by TGF-beta1 in hepatocytes.
Oncogene. 24:4580–4587. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Takami M, Love RB and Iwashima M: TGF-beta
converts apoptotic stimuli into the signal for Th9 differentiation.
J Immunol. 188:4369–4375. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang A, Pan D, Lee YH, Martinez GJ, Feng
XH and Dong C: Cutting Edge: Smad2 and Smad4 regulate
TGF-β-Mediated Il9 gene expression via EZH2 displacement. J
Immunol. 191:4908–4912. 2013. View Article : Google Scholar : PubMed/NCBI
|
